BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21738637)

  • 41. Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.
    Ringe RP; Yasmeen A; Ozorowski G; Go EP; Pritchard LK; Guttman M; Ketas TA; Cottrell CA; Wilson IA; Sanders RW; Cupo A; Crispin M; Lee KK; Desaire H; Ward AB; Klasse PJ; Moore JP
    J Virol; 2015 Dec; 89(23):12189-210. PubMed ID: 26311893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.
    Staropoli I; Chanel C; Girard M; Altmeyer R
    J Biol Chem; 2000 Nov; 275(45):35137-45. PubMed ID: 10926931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
    Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity.
    Usami Y; Göttlinger H
    Cell Rep; 2013 Nov; 5(3):802-12. PubMed ID: 24209751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
    Kumar R; Ozorowski G; Kumar V; Holden LG; Shrivastava T; Patil S; Deshpande S; Ward AB; Bhattacharya J
    J Biol Chem; 2017 Sep; 292(38):15849-15858. PubMed ID: 28743743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region.
    Labrosse B; Treboute C; Alizon M
    J Virol; 2000 Mar; 74(5):2142-50. PubMed ID: 10666243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.
    Yang X; Florin L; Farzan M; Kolchinsky P; Kwong PD; Sodroski J; Wyatt R
    J Virol; 2000 May; 74(10):4746-54. PubMed ID: 10775613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
    Gao F; Morrison SG; Robertson DL; Thornton CL; Craig S; Karlsson G; Sodroski J; Morgado M; Galvao-Castro B; von Briesen H; Beddows S; Weber J; Sharp PM; Shaw GM; Hahn BH
    J Virol; 1996 Mar; 70(3):1651-67. PubMed ID: 8627686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.
    Zhang P; Gorman J; Geng H; Liu Q; Lin Y; Tsybovsky Y; Go EP; Dey B; Andine T; Kwon A; Patel M; Gururani D; Uddin F; Guzzo C; Cimbro R; Miao H; McKee K; Chuang GY; Martin L; Sironi F; Malnati MS; Desaire H; Berger EA; Mascola JR; Dolan MA; Kwong PD; Lusso P
    Cell Host Microbe; 2018 Jun; 23(6):832-844.e6. PubMed ID: 29902444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling.
    Nakane S; Iwamoto A; Matsuda Z
    J Biol Chem; 2015 Jun; 290(24):15279-91. PubMed ID: 25911103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.
    Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK
    J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
    Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
    J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
    Witt KC; Castillo-Menendez L; Ding H; Espy N; Zhang S; Kappes JC; Sodroski J
    PLoS One; 2017; 12(2):e0170672. PubMed ID: 28151945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
    Day JR; Van Damme N; Guatelli JC
    Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Display of the HIV envelope protein at the yeast cell surface for immunogen development.
    Mathew E; Zhu H; Connelly SM; Sullivan MA; Brewer MG; Piepenbrink MS; Kobie JJ; Dewhurst S; Dumont ME
    PLoS One; 2018; 13(10):e0205756. PubMed ID: 30335821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.
    Bouvin-Pley M; Beretta M; Moreau A; Roch E; Essat A; Goujard C; Chaix ML; Moiré N; Martin L; Meyer L; Barin F; Braibant M
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers.
    Guenaga J; Dubrovskaya V; de Val N; Sharma SK; Carrette B; Ward AB; Wyatt RT
    J Virol; 2015 Dec; 90(6):2806-17. PubMed ID: 26719252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike.
    Ozorowski G; Pallesen J; de Val N; Lyumkis D; Cottrell CA; Torres JL; Copps J; Stanfield RL; Cupo A; Pugach P; Moore JP; Wilson IA; Ward AB
    Nature; 2017 Jul; 547(7663):360-363. PubMed ID: 28700571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.